MyFinsight
Home
Blog
About
Back
Income Statement
BioXcel Therapeutics, Inc. (BTAI)
BioXcel Therapeutics, Inc. (BTAI)
source: myfinsight.com
Net loss
-$14,713K
(23.32%↑ Y/Y)
Interest income
$131K
(-43.04%↓ Y/Y)
Loss from operations
-$10,193K
(35.70%↑ Y/Y)
Interest expense
$4,257K
(0.83%↑ Y/Y)
Other (income)
expense, net
-$394K
(-159.97%↓ Y/Y)
Product revenue, net
$182K
(51.67%↑ Y/Y)
Total operating
expenses
$10,375K
(-35.04%↓ Y/Y)
Selling, general and
administrative
$7,189K
(28.17%↑ Y/Y)
Research and development
$3,164K
(-69.15%↓ Y/Y)
Cost of goods sold
$22K
(-79.44%↓ Y/Y)
Back